Glycopyrrolate
- Product NDC
- 60505-6181
- 11-digit product format
- 605056181
- Labeler code
- 60505
- Product ID
- 60505-6181_248dc758-2771-b208-f748-18d8f2b998ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glycopyrrolate
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Apotex Corp.
- Application
- ANDA210246
- Marketing category
- ANDA
- Marketing start
- 2020-06-10
- Marketing end
- 0000-00-00
- Substance
- GLYCOPYRROLATE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-6181 | GLYCOPYRROLATE INJECTION [APOTEX CORP.] | 5 | Legacy NDC | 20240111_359d74e3-56ca-9a6b-85c5-a8b7f559cf55.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6181-5 | 60505618105 | 25 VIAL in 1 CARTON (60505-6181-5) > 5 mL in 1 VIAL | 25 vial | 2020-06-10 | 0000-00-00 | No | No | Current |